BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 38582329)

  • 1. The Emerging Role of Ubiquitin-Specific Protease 36 (USP36) in Cancer and Beyond.
    Niu MY; Liu YJ; Shi JJ; Chen RY; Zhang S; Li CY; Cao JF; Yang GJ; Chen J
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38785979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP9X-mediated REV1 deubiquitination promotes lung cancer radioresistance via the action of REV1 as a Rad18 molecular scaffold for cystathionine γ-lyase.
    Chen Y; Feng X; Wu Z; Yang Y; Rao X; Meng R; Zhang S; Dong X; Xu S; Wu G; Jie X
    J Biomed Sci; 2024 May; 31(1):55. PubMed ID: 38802791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deubiquitinase FAM/USP9X interacts with the E3 ubiquitin ligase SMURF1 protein and protects it from ligase activity-dependent self-degradation.
    Xie Y; Avello M; Schirle M; McWhinnie E; Feng Y; Bric-Furlong E; Wilson C; Nathans R; Zhang J; Kirschner MW; Huang SM; Cong F
    J Biol Chem; 2013 Feb; 288(5):2976-85. PubMed ID: 23184937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTORC2 Assembly Is Regulated by USP9X-Mediated Deubiquitination of RICTOR.
    Wrobel L; Siddiqi FH; Hill SM; Son SM; Karabiyik C; Kim H; Rubinsztein DC
    Cell Rep; 2020 Dec; 33(13):108564. PubMed ID: 33378666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitinase USP9X stabilizes RNA m
    Wang P; Wang J; Yao S; Cui M; Cheng Y; Liu W; Gao Z; Hu J; Zhang J; Zhang H
    J Biol Chem; 2023 Aug; 299(8):105055. PubMed ID: 37454738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment.
    Gao H; Chen Z; Zhao L; Ji C; Xing F
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189099. PubMed ID: 38582329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of USP9X in cellular functions and tumorigenesis (Review).
    Meng Y; Hong C; Yang S; Qin Z; Yang L; Huang Y
    Oncol Lett; 2023 Dec; 26(6):506. PubMed ID: 37920433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissenting degradation: Deubiquitinases in cell cycle and cancer.
    Bonacci T; Emanuele MJ
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):145-158. PubMed ID: 32201366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitination and deubiquitination: Implications on cancer therapy.
    Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. La FAM fatale: USP9X in development and disease.
    Murtaza M; Jolly LA; Gecz J; Wood SA
    Cell Mol Life Sci; 2015 Jun; 72(11):2075-89. PubMed ID: 25672900
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.